Development and Validation of the CARRA-VID Prognostic Score: C Reactive Protein to Albumin Ratio, Red Blood Cell Distribution Width and Age-Based Score for Prognostication of Hospitalized COVID-19 Patients
Viruses · 2025
DOI: 10.3390/v17050629 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift Viruses, 2025. Verfasst von Marko Lucijanic und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology, Internal Medicine Department, University Hospital Dubrava, 10000 Zagreb, Croatia. Hauptthemen laut MEDLINE: COVID-19, C-Reactive Protein, Erythrocyte Indices, Serum Albumin. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Patients hospitalized due to coronavirus disease 2019 (COVID-19) usually present with severe or critical intensity of symptoms, accompanied by a marked systemic inflammatory response. Classical inflammatory biomarkers, C-reactive protein (CRP), albumin, and red blood cell distribution width (RDW) have previously been reported to be prognostic in hospitalized COVID-19 patients. We performed a retrospective analysis of two large cohorts (2305 and 2328 patients, respectively) of consecutive hospitalized COVID-19 patients with mostly severe and critical symptoms admitted to the tertiary referral center to develop and validate a prognostic score for 30-day mortality based on CRP-to-Albumin-Ratio (CAR), RDW, and age (termed CARRA-VID score). We identified 6 prognostic categories: very low, low, intermediate-1, intermediate-2, high, and very high risk, with corresponding 30-day mortality rates of 2.7%, 10.7%, 30.9%, 47.1%, 61.9%, and 89.7%, respectively. Effective risk stratification was validated in an independent cohort of patients and remained independent of the World Health Organization-defined disease severity and other commonly utilized risk scores. Additional analyses evaluated the score across different time periods dominated by distinct viral variants. We also present a simplified 3-tiered version of the score. A Microsoft Excel Workbook containing the score calculator is provided.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Hematology, Internal Medicine Department, University Hospital Dubrava, 10000 Zagreb, Croatia.
- Scientific Research and Translational Medicine Department, University Hospital Dubrava, 10000 Zagreb, Croatia.
- School of Medicine, University of Zagreb, 10000 Zagreb, Croatia.
- Division of Pulmonology, Internal Medicine Department, University Hospital Dubrava, 10000 Zagreb, Croatia.
- Faculty of Pharmacy and Biochemistry, University of Zagreb, 10000 Zagreb, Croatia.
- Internal Medicine Department, University Hospital Dubrava, 10000 Zagreb, Croatia.
ORCID-Profile: Marko Lucijanic, Nevenka Piskac Zivkovic, Nikolina Busic, Josip Stojic, Armin Atic, Ivan Krecak, Ivica Luksic
Zitieren
APA
Lucijanic, M., Piskac Zivkovic, N., Busic, N., Stojic, J., Atic, A., Derek, L., Krecak, I., Barsic, B., & Luksic, I. (2025). Development and Validation of the CARRA-VID Prognostic Score: C Reactive Protein to Albumin Ratio, Red Blood Cell Distribution Width and Age-Based Score for Prognostication of Hospitalized COVID-19 Patients. Viruses. https://doi.org/10.3390/v17050629
Vancouver
Lucijanic M, Piskac Zivkovic N, Busic N, Stojic J, Atic A, Derek L, et al. Development and Validation of the CARRA-VID Prognostic Score: C Reactive Protein to Albumin Ratio, Red Blood Cell Distribution Width and Age-Based Score for Prognostication of Hospitalized COVID-19 Patients. Viruses. 2025. doi:10.3390/v17050629
BibTeX
@article{Lucijanic2025,
author = {Lucijanic, Marko and Piskac Zivkovic, Nevenka and Busic, Nikolina and Stojic, Josip and Atic, Armin and Derek, Lovorka and Krecak, Ivan and Barsic, Bruno and Luksic, Ivica},
title = {Development and Validation of the CARRA-VID Prognostic Score: C Reactive Protein to Albumin Ratio, Red Blood Cell Distribution Width and Age-Based Score for Prognostication of Hospitalized COVID-19 Patients},
journal = {Viruses},
year = {2025},
doi = {10.3390/v17050629}
}
EUVIMED